Journal of the Formosan Medical Association最新文献

筛选
英文 中文
Commentary on "The applications of high-flow nasal cannulas in Pediatric Intensive Care Units in Taiwan".
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-13 DOI: 10.1016/j.jfma.2025.02.016
Shubham Kumar, Rachana Mehta, Ranjana Sah, Amogh Verma
{"title":"Commentary on \"The applications of high-flow nasal cannulas in Pediatric Intensive Care Units in Taiwan\".","authors":"Shubham Kumar, Rachana Mehta, Ranjana Sah, Amogh Verma","doi":"10.1016/j.jfma.2025.02.016","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.02.016","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143425692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dexmedetomidine infusion on blood loss in orthognathic surgery: A retrospective study on its efficacy.
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-13 DOI: 10.1016/j.jfma.2025.02.009
Yen-Chu Hsiao, Yi-Ting Chang, Chi-Sheng Cheng, Kai-Hua Lien
{"title":"Dexmedetomidine infusion on blood loss in orthognathic surgery: A retrospective study on its efficacy.","authors":"Yen-Chu Hsiao, Yi-Ting Chang, Chi-Sheng Cheng, Kai-Hua Lien","doi":"10.1016/j.jfma.2025.02.009","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.02.009","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143425693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Handgrip strength is probably not a predictor of mortality in patients with cardiovascular disease.
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-12 DOI: 10.1016/j.jfma.2025.02.006
Josef Finsterer
{"title":"Handgrip strength is probably not a predictor of mortality in patients with cardiovascular disease.","authors":"Josef Finsterer","doi":"10.1016/j.jfma.2025.02.006","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.02.006","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fewer good-quality cleavage embryos in dydrogesterone-primed ovarian stimulation compared to GnRH antagonist protocol in POSEIDON group 4 patients.
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-11 DOI: 10.1016/j.jfma.2025.02.003
Nguyen Thi Lien Huong, Bui Thi Hanh, Nguyen Thi Bich Van, Phi Thi Tu Anh, Hoang Bao Long, Le Duc Thang, Tran Thu Thuy, Nguyen Thi Minh Thu, Dang Tuan Anh, Phan Ngoc Quy, Le Quang Do, Than Trong Thach, Jean Noel Hugues, Do Van Tien, Le Hoang
{"title":"Fewer good-quality cleavage embryos in dydrogesterone-primed ovarian stimulation compared to GnRH antagonist protocol in POSEIDON group 4 patients.","authors":"Nguyen Thi Lien Huong, Bui Thi Hanh, Nguyen Thi Bich Van, Phi Thi Tu Anh, Hoang Bao Long, Le Duc Thang, Tran Thu Thuy, Nguyen Thi Minh Thu, Dang Tuan Anh, Phan Ngoc Quy, Le Quang Do, Than Trong Thach, Jean Noel Hugues, Do Van Tien, Le Hoang","doi":"10.1016/j.jfma.2025.02.003","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.02.003","url":null,"abstract":"<p><strong>Objective: </strong>To compare the in vitro fertilization (IVF) outcomes of the progestin-primed ovarian stimulation (PPOS) protocol using dydrogesterone and the GnRH antagonist (GnRH-ant) protocol in POSEIDON group 4 patients.</p><p><strong>Methods: </strong>This retrospective cohort study analyzed 447 POSEIDON group 4 patients who underwent IVF at a single center. Patients were categorized into GnRH-ant (n = 281) and PPOS (n = 166) groups. Propensity score matching was employed to balance baseline characteristics, yielding 165 patients in each group for comparison. The primary outcomes were the number and quality of cleavage and blastocysts embryos. Secondary outcomes included clinical pregnancy and ongoing pregnancy rates after the first frozen embryo transfer.</p><p><strong>Results: </strong>Baseline characteristics were balanced between groups after matching. The PPOS group had a significantly lower number of good quality cleavage embryos (adjusted mean ratio 0.80, 95% CI 0.66-0.97) and blastocysts (adjusted mean ratio 0.77, 95% CI 0.62-0.96) compared to the GnRH-ant group. The number of cleavage embryos and good quality blastocysts was comparable between groups. Although not statistically significant, the clinical pregnancy (31.4% vs 36.8%) and ongoing pregnancy rates (20.3% vs 29.9%) after the first embryo transfer tended to be lower in the PPOS group.</p><p><strong>Conclusions: </strong>In POSEIDON group 4 patients, the PPOS protocol using dydrogesterone may be associated with lower embryo quality and pregnancy outcomes compared to the GnRH-ant protocol. Further prospective randomized trials are needed to validate these findings.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143408815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Letter to the Editor.
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-11 DOI: 10.1016/j.jfma.2025.02.010
Chun-Ming Hong, Chun-Jen Liu
{"title":"Response to Letter to the Editor.","authors":"Chun-Ming Hong, Chun-Jen Liu","doi":"10.1016/j.jfma.2025.02.010","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.02.010","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143408816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Comment on "Colchicine to prevent cardiovascular death after an acute myocardial infarction".
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-10 DOI: 10.1016/j.jfma.2025.01.022
Ting-Tse Lin, Lung-Chun Lin
{"title":"Response to Comment on \"Colchicine to prevent cardiovascular death after an acute myocardial infarction\".","authors":"Ting-Tse Lin, Lung-Chun Lin","doi":"10.1016/j.jfma.2025.01.022","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.01.022","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma".
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-10 DOI: 10.1016/j.jfma.2025.02.007
Erkan Topkan
{"title":"Comment on \"Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma\".","authors":"Erkan Topkan","doi":"10.1016/j.jfma.2025.02.007","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.02.007","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An IgG4-related autoimmune hepatitis patient with the prompt response to glucocorticoid therapy.
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-10 DOI: 10.1016/j.jfma.2025.02.005
Chia-Tse Weng, Hung-Wen Tsai, Ming-Tsung Hsieh, Chrong-Reen Wang
{"title":"An IgG4-related autoimmune hepatitis patient with the prompt response to glucocorticoid therapy.","authors":"Chia-Tse Weng, Hung-Wen Tsai, Ming-Tsung Hsieh, Chrong-Reen Wang","doi":"10.1016/j.jfma.2025.02.005","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.02.005","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to "Comment on sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma".
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-10 DOI: 10.1016/j.jfma.2025.02.004
Pei-Jui Luo, Chih-Horng Wu
{"title":"Response to \"Comment on sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma\".","authors":"Pei-Jui Luo, Chih-Horng Wu","doi":"10.1016/j.jfma.2025.02.004","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.02.004","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C.
IF 2.6 3区 医学
Journal of the Formosan Medical Association Pub Date : 2025-02-06 DOI: 10.1016/j.jfma.2025.01.026
Yen-Chun Chen, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing Tao Kuo, Lein-Ray Mo, Ching Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Kuo-Chih Tseng, Ming-Lung Yu
{"title":"High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C.","authors":"Yen-Chun Chen, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing Tao Kuo, Lein-Ray Mo, Ching Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Kuo-Chih Tseng, Ming-Lung Yu","doi":"10.1016/j.jfma.2025.01.026","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.01.026","url":null,"abstract":"<p><strong>Background/purpose: </strong>The risk of hepatocellular carcinoma (HCC) is increased in patients with chronic hepatitis C (CHC) and elevated alanine transaminase (ALT) levels. The association between HCC and ALT levels after interferon (IFN) or direct-acting antivirals (DAA) therapy is unclear.</p><p><strong>Methods: </strong>Patients with CHC receiving antiviral therapy were included in two large-scale cohorts in Taiwan (T-COACH and TACR). Posttreatment ALT levels were assessed at 24-weeks/12-weeks after the end-of-treatment with IFN/DAA. HCC risk after antiviral therapy were identified for evaluation.</p><p><strong>Results: </strong>Of 29,926 CHC patients enrolled in the study, 64%, 22.5%, and 13.5% had posttreatment healthy-normal (female, ≤19 U/L; male ≤30 U/L), high-normal (female, 19-40 U/L; male, 30-40 U/L), and abnormal (>40 U/L) ALT levels, respectively. During a median follow-up of 2.4 years, 1245 patients developed HCC. The 5-year cumulative HCC incidence was 11.2% and 5.2% in the abnormal and high-normal ALT groups, respectively, compared to 2.7% in the healthy ALT group. In Cox regression analysis, factors associated with a higher HCC risk were advanced fibrosis, abnormal and high-normal posttreatment ALT levels, cirrhosis, and old age; whereas a sustained virological response (SVR) was associated with a lower HCC risk. The aforementioned impacts of abnormal and high-normal posttreatment ALT levels were observed across the SVR, non-SVR, and non-cirrhotic subgroups.</p><p><strong>Conclusion: </strong>Patients with CHC with high-normal and abnormal posttreatment ALT levels have an increased risk of HCC; thus, HCC surveillance is still necessary in this population.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143370781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信